Director at Microbot Medical (NASDAQ: MBOT) gets 10,000 options

Rhea-AI Filing Summary

Microbot Medical Inc. director Madden Martin J. received a grant of stock options representing 10,000 shares of common stock. The options have an exercise price of $2.37 per share, were granted on April 1, 2026, and expire on April 1, 2036.

This is a compensation-related award, not an open-market purchase or sale, and leaves the director holding 10,000 options following the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Madden Martin J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	10,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 10,000 shares (Direct)

Footnotes (1)

Key Figures

Options granted: 10,000 options Exercise price: $2.37 per share Expiration date: April 1, 2036 +1 more

4 metrics

Options granted 10,000 options Stock Option (Right to Buy) granted April 1, 2026

Exercise price $2.37 per share Conversion or exercise price of granted options

Expiration date April 1, 2036 Options expiration for this grant

Options held after grant 10,000 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), grant/award acquisition, Common Stock, par value $0.01 per share, Form 4

4 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

grant/award acquisition financial

"transaction_action: "grant/award acquisition""

Common Stock, par value $0.01 per share financial

"underlying_security_title: "Common Stock, par value $0.01 per share""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Madden Martin J.

(Last) (First) (Middle)

C/O MICROBOT MEDICAL INC.

175 DERBY ST., BLD. 27

(Street)

HINGHAM MASSACHUSETTS 02043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Microbot Medical Inc. [ MBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.37	04/01/2026		A		10,000		04/01/2026	04/01/2036	Common Stock, par value $0.01 per share	10,000	$0	10,000	D

Explanation of Responses:

	/s/ Martin Madden	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MBOT director Madden Martin J. report?

Madden Martin J., a director of Microbot Medical Inc., reported receiving 10,000 stock options as a grant. These options give the right to buy common shares at a fixed price and represent compensation, not an open-market trade.

How many Microbot Medical (MBOT) options were granted in this Form 4?

The Form 4 shows a grant of 10,000 stock options to the director. Each option relates to one share of common stock, creating potential future ownership if the options are exercised at or above the exercise price.

What is the exercise price of the MBOT options granted to the director?

The granted options have an exercise price of $2.37 per share. This means the director can buy Microbot Medical common stock at $2.37 if the options are exercised before expiration, regardless of future market price levels.

When do the newly granted Microbot Medical (MBOT) options expire?

The options granted to the director expire on April 1, 2036. After that expiration date, any unexercised options become worthless, so the director must exercise them before this long-term deadline to receive common shares.

Did the MBOT director buy or sell shares in the market in this filing?

No market buy or sell took place in this filing. The director received a grant of 10,000 stock options at no cost, which is a compensation award rather than an open-market stock purchase or sale transaction.